Track PURE Bioscience's other current assets ($92K) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest other current assets for PURE is $92K as of April 2026. That compares with $88K in the prior-year period — up 4.5% year over year. Investors often review this figure alongside PURE Bioscience's historical trend and sector peers before judging valuation or financial health.
Over the past year, PURE's other current assets moved from $88K to $92K — a 4.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in PURE Bioscience's operating scale or balance-sheet position.
A other current assets figure of $92K for PURE is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting PURE's other current assets ($92K), review year-over-year change from $88K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.